AOD 9604
$60.00
AOD 9604 2/5mg Peptide for sale USA warehouse
weight: 2/5mg/vial 10vials/box
all name：Anti-Obesity Drug 9604
Description
AOD 9604 2mg peptide/vial hot sale online USA, buy to quality online.
AOD 9604, also known as “Anti-Obesity Drug 9604,” is a modified form of human growth hormone (GH). Here’s a brief overview of AOD 9604:
- Structure and Development: AOD 9604 is a peptide fragment derived from the C-terminal region of human GH (hGH), specifically from amino acids 177-191. This region is believed to be responsible for the lipolytic (fat-reducing) properties of GH.
- Mechanism of Action: AOD 9604 works by mimicking the lipolytic effects of GH without affecting blood sugar levels. It stimulates the breakdown of fat cells (lipolysis), promoting the release of stored fat for energy metabolism.
- Applications: AOD 9604 has been studied primarily for its potential as an anti-obesity agent. It is thought to selectively target adipose tissue (fat cells) and reduce body fat, particularly in problematic areas such as the abdomen.
- Clinical Studies: AOD 9604 has undergone various clinical trials to evaluate its safety and efficacy in reducing body fat. Results from these studies have shown mixed outcomes, with some demonstrating significant fat loss benefits and others showing minimal effects.
- Safety Profile: AOD 9604 is generally considered to have a favorable safety profile, with minimal side effects reported in clinical trials. However, as with any therapeutic peptide, careful monitoring is necessary to assess long-term safety and potential interactions.
- Regulatory Status: AOD 9604 is not approved for medical use in most countries, including the United States and Australia. It is primarily used in research settings and is not available for commercial use as a pharmaceutical drug.
In summary, AOD 9604 is a peptide fragment derived from human growth hormone, studied for its potential as an anti-obesity agent by promoting fat breakdown. While promising in some studies, its clinical use remains limited pending further research and regulatory approval.
effect
AOD 9604, a modified fragment of human growth hormone (hGH), is primarily studied for its potential effects on reducing body fat, particularly abdominal fat. Here are the key effects associated：
- Lipolytic Activity: AOD 9604 mimics the lipolytic (fat-reducing) effects of hGH. It promotes the breakdown of stored fat (lipolysis) by stimulating the release of fatty acids from adipose tissue. This process is believed to occur without affecting blood sugar levels, making it potentially advantageous compared to full-length hGH.
- Fat Reduction: Clinical studies and research trials have indicated that AOD 9604 can lead to significant reductions in body fat, particularly in areas such as the abdomen. It targets adipose tissue, where fat accumulation is often problematic.
- Enhanced Metabolism: By increasing fat metabolism, AOD 9604 may help improve overall metabolic function. This could potentially contribute to weight loss and body composition improvements, especially in individuals with excess adiposity.
- Potential Benefits: Beyond fat reduction, has been suggested to have potential benefits such as improved lipid profiles (cholesterol levels) and metabolic parameters. These effects could be beneficial for individuals at risk of obesity-related complications.
- Limited Side Effects: AOD 9604 is generally considered to have a favorable safety profile based on available clinical data. Side effects reported in studies have been minimal, with no significant adverse effects observed in most participants.
In summary, shows potential as a selective lipolytic agent that targets fat tissue, particularly abdominal fat, with minimal impact on blood sugar levels. While further research is needed to fully establish its efficacy and safety, initial findings suggest it could be a promising option for managing obesity and related metabolic conditions in the future.
side effect
A peptide fragment derived from human growth hormone (hGH), has been studied primarily for its potential as an anti-obesity agent. Here are some considerations regarding its side effects based on available research and clinical studies:
- Safety Profile: is generally considered to have a favorable safety profile. Clinical trials and studies have reported minimal adverse effects compared to full-length hGH.
- Minimal Side Effects: Reported side effects from studies include mild reactions at the injection site, such as redness or irritation. These are typical of peptide-based medications and are generally well-tolerated.
- Blood Glucose Levels: Unlike full-length hGH, which can affect insulin sensitivity and blood glucose levels, is believed to exert its lipolytic effects without significantly altering glucose metabolism. This may reduce the risk of glucose-related side effects commonly associated with hGH therapy.
Welcome to Inquiry:
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 20 × 20 × 20 cm |
| weight | 2mg/vial |
Reviews
There are no reviews yet.